IL1B and Parkinson disease: Similarly, findings in a different PD model involving rotenone-induced toxicity in microglial BV2 cells, showed that pre-treatment with luteolin at 1 μM increased cell viability from 40% to 80%, decreased IL-1β by 70% and regulated oxidative stress, thus protecting microglia [71].